PNB Vesper completes Phase 2 of clinical trials of GPP-Baladol on COVID-19 patients
Clinical trial report to be submitted to Drug Controller General of India on February 22, 2021
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GPP Baladol
PNB Vesper to commence phase II clinical trial of COVID-19 drug in BJ Medical College, Pune
The company has already patented the molecule and secured intellectual property rights in the US, Europe and rest of the world